New Assay May Help Improve Detection of Prion Diseases

This article originally appeared here.
Share this content:
New Assay May Help Improve Detection of Prion Diseases
New Assay May Help Improve Detection of Prion Diseases

WEDNESDAY, April 13, 2016 (HealthDay News) -- A timed in vitro prion protein (PrP) conversion protocol is sensitive for detecting elk chronic wasting disease (CWD) in brain tissues, according to research published online April 8 in the Journal of Molecular Diagnostics.

As a novel technique for identification of prion disease, John G. Gray, from the Canadian Food Inspection Agency in Lethbridge, and colleagues present a timed in vitro PrP conversion protocol with accurate, well-defined analytical criteria based on probability density and mass functions of transmissible spongiform encephalopathy (TSE)+ and TSE associated thioflavin T signal times. The method was used in elk CWD in brain tissues.

The researchers found that the sensitivity of the protocol and analytical criteria were similar to those of two bioassay models, and more than 1.2 log10 more sensitive than the most sensitive rapid test for TSE. Timing in vitro PrP conversion could be used to titrate TSE infectivity.

"Our results further support that timing in vitro PrP conversion is a plausible method to titrate TSE infectivity," the authors write. "This study embodies the first comprehensive analytical sensitivity comparison between an amyloid seeding assay, bioassay, and multiple TSE rapid tests, thus providing considerable insight into the operating range relation between these TSE detection methods."

The study was supported by the Alberta Livestock and Meat Agency.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Plan to Relax Coal-Fired Power Plant Rules Could Up Mortality

Plan to Relax Coal-Fired Power Plant Rules Could ...

EPA predicts between 470 and 1,400 premature deaths a year by 2030

FDA Extends EpiPen Expiration Dates to Tackle Shortage

FDA Extends EpiPen Expiration Dates to Tackle Shortage

Shortages due to factors such as supply disruptions and manufacturer issues

USPSTF Updates Guidance for Cervical Cancer Screening

USPSTF Updates Guidance for Cervical Cancer Screening

Cytology recommended every three years from age 21; different screening options from age 30 to 65

is free, fast, and customized just for you!




Already a member?

Sign In Now »